"
Psoriatic Arthritis Global Clinical Trials Review, H1, 2016 "is
the latest addition to MRR.Biz industry research reports collection.
GlobalData's
clinical trial report, Psoriatic
Arthritis Global Clinical Trials Review, H1, 2016"
provides an overview of Psoriatic Arthritis clinical trials scenario.
This report provides top line data relating to the clinical trials on
Psoriatic Arthritis. Report includes an overview of trial numbers and
their average enrollment in top countries conducted across the globe.
The report offers coverage of disease clinical trials by region,
country (G7 & E7), phase, trial status, end points status and
sponsor type. Report also provides prominent drugs for in-progress
trials (based on number of ongoing trials). GlobalData Clinical Trial
Reports are generated using GlobalDatas proprietary database - Pharma
eTrack Clinical trials database. Clinical trials are collated from
80+ different clinical trial registries, conferences, journals, news
etc across the globe. Clinical trials database undergoes periodic
update by dynamic process.
The
report enhances the decision making capabilities and helps to create
an effective counter strategies to gain competitive advantage.
Download Sample copy of this
Report at :
http://www.marketresearchreports.biz/sample/sample/728950
Scope
-
The report provides a snapshot of the global clinical trials
landscape
-
Report provides top level data related to the clinical trials by
Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor
Type and End point status
-
The report reviews top companies involved and enlists all trials
(Trial title, Phase, and Status) pertaining to the company
-
The report provides all the unaccomplished trials (Terminated,
Suspended and Withdrawn) with reason for unaccomplishment
-
The Report provides enrollment trends for the past five years
-
Report provides latest news for the past three months
Reasons to buy
-
Assists in formulating key business strategies with regards to
investment
-
Helps in identifying prominent locations for conducting clinical
trials which saves time and cost
-
Provides top level analysis of Global Clinical Trials Market which
helps in identifying key business opportunities
-
Supports understanding of trials count and enrollment trends by
country in global therapeutics market
-
Aids in interpreting the success rates of clinical trials by
providing a comparative scenario of completed and uncompleted
(terminated, suspended or withdrawn) trials
-
Facilitates clinical trial assessment of the indication on a global,
regional and country level
Browse
Press Releases by Prweb :
Table
of Contents
Table
of Contents
Table
of Contents 2
List
of Tables 3
List
of Figures 4
Report
Guidance 5
Clinical
Trials by Region 6
Clinical
Trials and Average Enrollment by Country 7
Top
Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top
Five Countries Contributing to Clinical Trials in Europe 11
Top
Countries Contributing to Clinical Trials in North America 12
Top
Countries Contributing to Clinical Trials in Middle East and Africa
13
Top
Five Countries Contributing to Clinical Trials in Central and South
America 14
Clinical
Trials by G7 Countries: Proportion of Psoriatic Arthritis to
Musculoskeletal Disorders Clinical Trials 15
Clinical
Trials by Phase in G7 Countries 16
Clinical
Trials in G7 Countries by Trial Status 17
Clinical
Trials by E7 Countries: Proportion of Psoriatic Arthritis to
Musculoskeletal Disorders Clinical Trials 18
Clinical
Trials by Phase in E7 Countries 19
Clinical
Trials in E7 Countries by Trial Status 20
Clinical
Trials by Phase 21
In
Progress Trials by Phase 22
Clinical
Trials by Trial Status 23
Clinical
Trials by End Point Status 24
Subjects
Recruited Over a Period of Time 25
Clinical
Trials by Sponsor Type 26
Prominent
Sponsors 27
Top
Companies Participating in Psoriatic Arthritis Therapeutics Clinical
Trials 28
Prominent
Drugs 29
Latest
Clinical Trials News on Psoriatic Arthritis 30
Apr
25, 2016: AbGenomics International Announces Promising Final Results
from their Phase II Open-Label Clinical Study of AbGn-168H /
Neihulizumab in Psoriatic Arthritis, a T-cell Mediated Disease 30
Apr
05, 2016: Pfizer Announces Positive Top-Line Results From The First
Phase 3 Trial Of Investigational Tofacitinib In Adults With Psoriatic
Arthritis 30
Mar
16, 2016: Significantly higher persistence with SIMPONI (golimumab)
in patients with rheumatic diseases compared with other subcutaneous
TNF-alpha inhibitors, new study reveals 31
Mar
04, 2016: Oral OTEZLA (apremilast) Data from Open-Label Phase of
ESTEEM and LIBERATE Trials to Be Presented at American Academy of
Dermatology Congress 31
Mar
01, 2016: Lilly To Present Phase 3 Data At The American Academy Of
Dermatology Annual Meeting For Ixekizumab In Psoriasis And Psoriatic
Arthritis 33
Clinical
Trial Profile Snapshots 35
Appendix
217
Abbreviations
217
Definitions
217
Research
Methodology 218
Secondary
Research 218
About
GlobalData 219
Contact
Us 219
Disclaimer
219
About us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
Mr.
Nachiket
State Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
No comments:
Post a Comment